OrganonMEX:OGN 59 EV-to-FCF is 17.97 as of Jun. 29, 2026, which is 21% below its 10-year median of 22.66. GuruFocus rates MEX:OGN with a GF Score™ of 59/100 and a GF Value™ of MXN246.81 (Fairly Valued). The stock has 10 warning signs investors should review. Among 559 Drug Manufacturers companies, Organon ranks better than 53.85% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Organon's Enterprise Value is MXN192,670 Mil.
Organon's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN10,720 Mil. Therefore, Organon's EV-to-FCF for today is 17.97.
The historical rank and industry rank for Organon's EV-to-FCF or its related term are showing as below:
MEX:OGN'
s EV-to-FCF Range Over the Past 10 Years
Min: 3.21 Med: 22.66 Max: 111.04
Current: 18.83
During the past 8 years, the highest EV-to-FCF of Organon was 111.04. The lowest was 3.21. And the median was 22.66.
MEX:OGN's EV-to-FCF is ranked better than 53.85% of 559
companies
in the Drug Manufacturers industry
Industry Median: 20.02
vs MEX:OGN: 18.83
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-06-29), Organon's stock price is MXN229.00.
Organon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN17.421. Therefore, Organon's PE Ratio (TTM) for today is 13.15.
Organon (MEX:OGN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Organon's share price for today is MXN229.00.
Organon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN17.421.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Organon EV-to-FCF Related Terms
Organon EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Organon's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Organon's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organon EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organon's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Organon's EV-to-FCF falls into.
Organon's current Enterprise Value is MXN192,670 Mil.
Organon's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN10,720 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organon (MEX:OGN) has a EV-to-FCF of 17.97 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Organon and its competitors. This is 21% below median its historical median of 22.66. Over the past decade, Organon's EV-to-FCF has ranged from 3.21 to 111.04. According to the industry distribution chart, Organon ranks #258 out of 559 companies in the Drug Manufacturers industry, placing it in the top 46.2%.
Is Organon's EV-to-FCF too high?
Organon's current EV-to-FCF of 17.97 is 21% below median its 10-year median of 22.66. Over the past 10 years, this metric has ranged from a low of 3.21 to a high of 111.04. The Drug Manufacturers industry median EV-to-FCF is 20.02. Organon's value of 17.97 is 10.2% below this industry median. Based on the distribution chart, Organon ranks #258 out of 559 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Organon has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Organon's EV-to-FCF compare to AMRN and SCLX?
According to the Drug Manufacturers industry distribution chart, Organon ranks #258 out of 559 companies for EV-to-FCF. This puts Organon in the upper half of its industry. The industry median EV-to-FCF is 20.02. Organon's value of 17.97 is 10.2% below this benchmark. Historically, Organon's own EV-to-FCF has ranged from 3.21 to 111.04 over the past decade. While the company's 10-year median is 22.66 vs. the industry median of 20.02, Organon has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.02, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organon's current EV-to-FCF of 17.97 is 10.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Organon and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organon's current EV-to-FCF is 17.97, which is 21% below median its own 10-year median of 22.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organon stock overvalued right now?
Based on GuruFocus' analysis, Organon (MEX:OGN) is currently considered Fairly Valued. The stock's GF Value™ is MXN246.81, compared to a current price of MXN229.00 — trading 7.2% below its estimated fair value. The current EV-to-FCF is 17.97, which is 21% below median its 10-year median of 22.66 and 10.2% below the Drug Manufacturers industry median of 20.02. Organon's overall GF Score™ is 59/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Organon (MEX:OGN), the current EV-to-FCF is 17.97 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organon (MEX:OGN) Overvalued in 2026?
Based on GuruFocus' analysis, Organon stock appears to be undervalued.
The current stock price of MXN229.00 is trading 7.2% below its estimated GF Value™ of MXN246.81.
GuruFocus considers Organon to be Fairly Valued.
Key valuation signals for MEX:OGN:
EV-to-FCF: 17.97 (21% below median its 10-year median of 22.66)
GF Value™: MXN246.81 vs. price of MXN229.00 (7.2% below fair value)
Industry Position: 10.2% below the Drug Manufacturers median (#258 of 559)
No single metric tells the full story. See the MEX:OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
59GF Score
Get the complete analysis for MEX:OGN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OGN has been successfully added to your 
